[用皮质类固醇脉冲进行诱导治疗以治疗颞动脉炎] - Suppr

Suppr

超能文献

[Induction therapy with corticoid pulses for treatment of temporal arteritis].

作者信息

Krüger K

机构信息

Praxiszentrum St. Bonifatius, St. Bonifatius Str. 5, 81541 München.

出版信息

Z Rheumatol. 2007 Mar;66(2):165-6. doi: 10.1007/s00393-007-0148-6.

DOI:10.1007/s00393-007-0148-6

PMID:17294060

Abstract

摘要

相似文献

[Induction therapy with corticoid pulses for treatment of temporal arteritis].

Z Rheumatol. 2007 Mar;66(2):165-6. doi: 10.1007/s00393-007-0148-6.

Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.

Arthritis Rheum. 2006 Oct;54(10):3310-8. doi: 10.1002/art.22163.

Benefit of high-dose intravenous methylprednisolone as induction therapy for giant cell arteritis: comment on the article by Mazlumzadeh et al.

Arthritis Rheum. 2007 May;56(5):1722; author reply 1723-4. doi: 10.1002/art.22575.

Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids.

Arch Dermatol. 1996 Dec;132(12):1435-9.

[Non-complicated Horton's disease: initial treatment with methylprednisolone 500 mg/day bolus for three days followed by 20 mg/day prednisone-equivalent. Evaluation of 15 patients].

Rev Med Interne. 2001 Nov;22(11):1032-8. doi: 10.1016/s0248-8663(01)00468-4.

Are there differences in type, dosage, and method of administration for the systemic steroids in IBD treatment?

Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S216-8. doi: 10.1002/ibd.20728.

Bilateral ocular ischemic syndrome secondary to giant cell arteritis progressing despite corticosteroid treatment.

Am J Ophthalmol. 1999 Jan;127(1):102-4. doi: 10.1016/s0002-9394(98)00313-4.

The use of pulse corticosteroid therapy for juvenile dermatomyositis.

Pediatr Dermatol. 1996 Jul-Aug;13(4):347-8. doi: 10.1111/j.1525-1470.1996.tb01253.x.

[Bolus of methylprednisolone and Horton's disease/rhizomelic pseudo-polyarthritis. Preliminary results of a pilot study of treating the bolus with low doses of corticoids].

Ann Med Interne (Paris). 1992;143(2):85-8.

Differences between active treatment and placebo groups in the study of induction treatment of giant cell arteritis with high-dose glucocorticoids: comment on the article by Mazlumzadeh et al.

Arthritis Rheum. 2007 May;56(5):1723; author reply 1723-4. doi: 10.1002/art.22576.

本文引用的文献

Giant cell arteritis--the methotrexate debate revisited.

J Rheumatol. 2006 Jul;33(7):1458-9.

Novel therapeutic strategies for large vessel vasculitis.

Rheum Dis Clin North Am. 2006 Feb;32(1):173-86, xi. doi: 10.1016/j.rdc.2005.09.006.

[Polymyalgia rheumatica: myalgic syndrome or occult vasculitis?].

Internist (Berl). 2005 Nov;46(11):1233-43. doi: 10.1007/s00108-005-1491-9.

Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.

Arthritis Rheum. 2003 Oct 15;49(5):703-8. doi: 10.1002/art.11388.

Giant-cell arteritis and polymyalgia rheumatica.

Ann Intern Med. 2003 Sep 16;139(6):505-15. doi: 10.7326/0003-4819-139-6-200309160-00015.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

[Induction therapy with corticoid pulses for treatment of temporal arteritis].

作者信息

Krüger K

机构信息

Praxiszentrum St. Bonifatius, St. Bonifatius Str. 5, 81541 München.

出版信息

Z Rheumatol. 2007 Mar;66(2):165-6. doi: 10.1007/s00393-007-0148-6.

DOI:10.1007/s00393-007-0148-6

PMID:17294060

Abstract

摘要

相似文献

[Induction therapy with corticoid pulses for treatment of temporal arteritis].

Z Rheumatol. 2007 Mar;66(2):165-6. doi: 10.1007/s00393-007-0148-6.

Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.

Arthritis Rheum. 2006 Oct;54(10):3310-8. doi: 10.1002/art.22163.

Benefit of high-dose intravenous methylprednisolone as induction therapy for giant cell arteritis: comment on the article by Mazlumzadeh et al.

Arthritis Rheum. 2007 May;56(5):1722; author reply 1723-4. doi: 10.1002/art.22575.

Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids.

Arch Dermatol. 1996 Dec;132(12):1435-9.

[Non-complicated Horton's disease: initial treatment with methylprednisolone 500 mg/day bolus for three days followed by 20 mg/day prednisone-equivalent. Evaluation of 15 patients].

Rev Med Interne. 2001 Nov;22(11):1032-8. doi: 10.1016/s0248-8663(01)00468-4.

Are there differences in type, dosage, and method of administration for the systemic steroids in IBD treatment?

Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S216-8. doi: 10.1002/ibd.20728.

Bilateral ocular ischemic syndrome secondary to giant cell arteritis progressing despite corticosteroid treatment.

Am J Ophthalmol. 1999 Jan;127(1):102-4. doi: 10.1016/s0002-9394(98)00313-4.

The use of pulse corticosteroid therapy for juvenile dermatomyositis.

Pediatr Dermatol. 1996 Jul-Aug;13(4):347-8. doi: 10.1111/j.1525-1470.1996.tb01253.x.

[Bolus of methylprednisolone and Horton's disease/rhizomelic pseudo-polyarthritis. Preliminary results of a pilot study of treating the bolus with low doses of corticoids].

Ann Med Interne (Paris). 1992;143(2):85-8.

Differences between active treatment and placebo groups in the study of induction treatment of giant cell arteritis with high-dose glucocorticoids: comment on the article by Mazlumzadeh et al.

Arthritis Rheum. 2007 May;56(5):1723; author reply 1723-4. doi: 10.1002/art.22576.

本文引用的文献

Giant cell arteritis--the methotrexate debate revisited.

J Rheumatol. 2006 Jul;33(7):1458-9.

Novel therapeutic strategies for large vessel vasculitis.

Rheum Dis Clin North Am. 2006 Feb;32(1):173-86, xi. doi: 10.1016/j.rdc.2005.09.006.

[Polymyalgia rheumatica: myalgic syndrome or occult vasculitis?].

Internist (Berl). 2005 Nov;46(11):1233-43. doi: 10.1007/s00108-005-1491-9.

Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.

Arthritis Rheum. 2003 Oct 15;49(5):703-8. doi: 10.1002/art.11388.

Giant-cell arteritis and polymyalgia rheumatica.

Ann Intern Med. 2003 Sep 16;139(6):505-15. doi: 10.7326/0003-4819-139-6-200309160-00015.